Viewing Study NCT00875667


Ignite Creation Date: 2025-12-25 @ 12:33 AM
Ignite Modification Date: 2025-12-31 @ 12:43 AM
Study NCT ID: NCT00875667
Status: COMPLETED
Last Update Posted: 2019-09-16
First Post: 2009-04-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Sponsor: Celgene
Organization: